SANTA CLARA, Calif. & BOSTON--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Cartagenia today announced that they have signed a definitive agreement under which Agilent will acquire Cartagenia, a leading provider of software and services for clinical genetics and molecular pathology labs. Cartagenia, which has offices in Leuven, Belgium, and Boston, Massachusetts, provides software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing
| < Prev | Next > |
|---|
